Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009;49(9):21-6.

[The use of atorvastatin in patients with rheumatoid arthritis with hyperlipidemia]

[Article in Russian]
  • PMID: 19772499
Randomized Controlled Trial

[The use of atorvastatin in patients with rheumatoid arthritis with hyperlipidemia]

[Article in Russian]
N M Nikitina et al. Kardiologiia. 2009.

Abstract

Aim: To assess efficacy and tolerability of atorvastatin and its lipid lowering and antiinflammatory effects as well as action on function of endothelium and elastic properties of arteries in patients with rheumatoid arthritis (RA) and hyperlipidemia.

Material: Patients with RA (n=50) were divided into 2 groups. The main group comprised 30 patients receiving atorvastatin (10 mg/day) as a component of complex therapy. The group of comparison comprised 20 patients with similar clinical characteristics and baseline lipid levels.

Results: The use of atorvastatin in complex therapy led not only to lowering of levels of atherogenic fractions of lipids but also to substantial lowering of levels of systemic inflammation and diminishment of endothelial damage. Positive action of 6 month therapy with atorvastatin on elastic properties of arteries was demonstrated. Tolerability of atorvastatin was good.

Conclusion: The data obtained allow to recommend the use of atorvastatin for long term management of hyperlipidemia in patients with RA.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources